The PALB2 truncating mutation c.1653T>A (p.Tyr551Stop) was identified in a woman diagnosed with an infiltrating ductal carcinoma (IDC), negative for estrogen receptor (ER), progesterone receptor (PR) and HER2 at the age of 36. This evidence concerns the gene ESR1 and invasive ductal breast carcinoma.